Skip to main content

Table 2 Chemotherapy and radiation therapy treatment parameters.

From: A phase II randomized trial comparing radiotherapy with concurrent weekly cisplatin or weekly paclitaxel in patients with advanced cervical cancer

 

Group I

Group II

Chemotherapy cycles

5 (3-6) *

5 (1-6) *

>4 cycles

14 (87%) *

12 (80%) *

EBRT dose

40 (40-66) *

40 (40-66) *

Dose to point A

33 (5-52) *

34 (0-58) *

No UV brachytherapy

3 (19%) *

6 (40%) *

Total dose to point A

75 (60-93) *

66 (40-98) *

  1. Group I received concurrent cisplatin and group II received concurrent paclitaxel.
  2. * Numbers represent number of patients with percentages when indicated, or median values with ranges (shown in parentheses).
  3. EBRT = external beam radiotherapy; UV=uterovaginal
Back to article page